Pipeline

Overview

Product Pipeline

Research
Preclinical
Phase 1
Complement
SQ CB 4332
Enhanced CFI
Research
Preclinical
Phase 1
SQ CB 4332
Enhanced CFI
IVT CB 2782-PEG
C3 degrader for Dry AMD
Research
Preclinical
Phase 1
IVT CB 2782-PEG
C3 degrader for Dry AMD
C3b/C4b degraders
Research
Preclinical
Phase 1
C3b/C4b degraders
C3a/C5a degraders
Research
Preclinical
Phase 1
C3a/C5a degraders

Partnering Opportunities

Hemostasis

SQ Marzeptacog alfa (FVIIa) “MarzAA”

  • Hemophilia A or B with inhibitors
  • FVIID/Glanzmann/Hemlibra

SQ Dalcinonacog alfa (FIX) “DalcA”

  • Hemophilia B

CB 2679d-GT

  • Hemophilia B FIX Gene Therapy
X